About The Third Affiliated Hospital of Qiqihar Medical University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Angde Biotech Pharmaceutical Co., Ltd.
1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
1
Harbin Medical University
1
Shanghai Henlius Biotech
1
Shenyang Northern Hospital
1
Zensun Sci. & Tech. Co., Ltd.
1
Clinical Trials at The Third Affiliated Hospital of Qiqihar Medical University
During the past decade, The Third Affiliated Hospital of Qiqihar Medical University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
2012-11-01
2015-03-01
Completed
14,032
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.
2018-07-23
2023-02-01
Unknown status
1,600
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
2019-08-14
2023-01-01
Active, not recruiting
537
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
2020-10-27
2025-04-30
Recruiting
8,250
A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy
2021-12-09
2023-07-01
Recruiting
40
A Study of r-PA Treating Patients With Acute Ischemic Stroke
2022-03-21
2023-06-01
Active, not recruiting
1,412
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Third Affiliated Hospital of Qiqihar Medical University" #1 sponsor was "Angde Biotech Pharmaceutical Co., Ltd." with 1 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials
sponsored, "Harbin Medical University" with 1 trials sponsored, "Shanghai Henlius Biotech" with 1 trials sponsored and "Shenyang Northern Hospital"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Third Affiliated Hospital of Qiqihar Medical University"
#1 collaborator was "Beijing Tiantan Hospital" with 1 trials as a collaborator, "Chinese Society of Cardiology" with 1 trials as a collaborator, "Guangdong Provincial People's Hospital" with 1 trials as a collaborator and "Lepu Medical Technology (Beijing) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at The Third Affiliated Hospital of Qiqihar Medical University
According to Clinical.Site data, the most researched conditions in "The Third Affiliated Hospital of Qiqihar Medical University" are
"Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Ischemic Stroke" (1 trials), "Advanced Cervical Cancer" (1 trials) and "Arterial Occlusive Diseases" (1 trials). Many other conditions were trialed in "The Third Affiliated Hospital of Qiqihar Medical University" in a lesser frequency.
Clinical Trials Intervention Types at The Third Affiliated Hospital of Qiqihar Medical University
Most popular intervention types in "The Third Affiliated Hospital of Qiqihar Medical University" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Aspirin monotherapy" (1 trials), "Clopidogrel and Aspirin dual-antiplatelet therapy" (1 trials), "HLX10" (1 trials) and "Injection of recombinant human tissue plasminogen kinase derivatives" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Third Affiliated Hospital of Qiqihar Medical University
The vast majority of trials in "The Third Affiliated Hospital of Qiqihar Medical University" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at The Third Affiliated Hospital of Qiqihar Medical University
Currently, there are NaN active trials in "The Third Affiliated Hospital of Qiqihar Medical University".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in The Third Affiliated Hospital of Qiqihar Medical University,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Third Affiliated Hospital of Qiqihar Medical University, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".